Syntric Medical raises €500,000 to advance precision lung biopsies

Venture Challenge alumnus Syntric Medical has secured €500,000 in pre-seed funding from BOM (Brabant Development Agency), imec.istart, Graduate Ventures and RoundOne. The investment will help the Eindhoven startup further develop and validate its robotic technology for more accurate lung biopsies, bringing it another step closer to patients.

Syntric Medical is tackling a challenge that sits between detecting a suspicious spot in the lung and reaching a clear diagnosis: getting an accurate tissue sample.

Doctors need that sample to determine whether cancer is present and which care is appropriate. But small abnormalities can be difficult to reach, particularly when breathing keeps the target moving. An inconclusive biopsy can mean another procedure, delayed treatment and more time spent waiting for answers.

Helping doctors reach a moving target

Syntric Medical’s patented robotic platform is designed to assist interventional radiologists with accurate needle placement in small targets. It uses live CT images while accounting for respiratory movement, with the aim of getting needle placement right the first time.

Developed in close collaboration with interventional radiologists, the technology is intended to fit into existing hospital workflows. Its ambition is to reduce inconclusive biopsies and repeat procedures, helping patients reach a reliable diagnosis sooner.

Lung biopsies are the starting point. The platform could also support other procedures in the chest and abdomen, such as liver ablation, where breathing makes precise needle placement difficult.

Funding the next steps

The pre-seed investment will support further development and preclinical validation. Syntric Medical will also seek early FDA feedback through a pre-submission process and assess healthcare providers’ demand and willingness to pay. These steps will help the team evaluate both the technology and its prospects for adoption; they do not constitute regulatory approval.

“With this investment we can move our technology a step closer to the patient.”
- Joric Oude Vrielink, CEO of Syntric Medical

The funding round remains open to investors until 31 December 2026.

From engineering expertise to patient impact

A spin-off from Eindhoven University of Technology, Syntric Medical combines robotics expertise with a clinical need: helping doctors turn a suspicious finding into a reliable diagnosis.

Adapted from: Syntric Medical aims to… | De Brabantse Ontwikkelings Maatschappij

Lachende teamleden van Syntric Medical

‹ News overview